Aditxt, Inc.

Aditxt, Inc.

Biotechnology • Healthcare • Mountain View, CA, United States • ADTX (NCM)

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

650 870 1200 2569 Wyandotte Street, Mountain View, CA 94043, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

$ADTX stock is down 26% today. Here's what we see in our data. - Quiver Quantitative
Quiver Quantitative • Dec 18
Aditxt (Nasdaq: ADTX) outlines bitXbio plan, Pearsanta 2026 IPO and Evofem stake - Stock Titan
Stock Titan • Nov 18
What Sparked Aditxt (ADTX) Stock's 52% After‑Hours Surge? - Sahm
Sahm • Dec 16
Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025 - ts2.tech
ts2.tech • Dec 17
Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting - PR Newswire
PR Newswire • Sep 9

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Aditxt, Inc. had layoffs?
No layoff events have been recorded for Aditxt, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Aditxt, Inc. have?
Aditxt, Inc. has approximately 26 employees.
What industry is Aditxt, Inc. in?
Aditxt, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Aditxt, Inc. a publicly traded company?
Yes, Aditxt, Inc. is publicly traded under the ticker symbol ADTX on the NCM. The company has a market capitalization of approximately $0.00 billion.
Where is Aditxt, Inc. headquartered?
Aditxt, Inc. is headquartered in Mountain View, CA, United States at 2569 Wyandotte Street, Mountain View, CA 94043, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.